# Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

Study · id `cardio:ct-nct01190007` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01190007](<https://clinicaltrials.gov/study/NCT01190007>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01190007

Browse, organ or system: Heart; Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; High blood pressure; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

## Technical summary

Registry record NCT01190007. Non-randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2012-12-03.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 159 participants (enrolled count; ClinicalTrials.gov record NCT01190007, source copy `cardio:ctgov-nct01190007-2021-01-28`, retrieved 2026-10-26)
- Start date: 2010-08 (registry gives no type) (ClinicalTrials.gov record NCT01190007, source copy `cardio:ctgov-nct01190007-2021-01-28`, retrieved 2026-10-26)
- Primary completion: 2012-02 (actual) (ClinicalTrials.gov record NCT01190007, source copy `cardio:ctgov-nct01190007-2021-01-28`, retrieved 2026-10-26)
- Completion: 2012-02 (actual) (ClinicalTrials.gov record NCT01190007, source copy `cardio:ctgov-nct01190007-2021-01-28`, retrieved 2026-10-26)
- Results first posted: 2012-12-03 (ClinicalTrials.gov record NCT01190007, source copy `cardio:ctgov-nct01190007-2021-01-28`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01190007, source copy `cardio:ctgov-nct01190007-2021-01-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01190007-2021-01-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
- Condition: Hypertension
- Condition: Hypercholesterolemia
- Condition: Angina Pectoris
- Intervention (Drug): Caduet
- Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (`cardio:org-pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc`)

## Provenance

Content hash: 40e25c4a446ae813a299d527bfe030d24b2f9c92ecbf3255246a5f429b145721
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
